Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
83.46 USD | -0.82% | +8.26% | +8.11% |
May. 06 | Argus Adjusts Price Target on Bio-Techne to $95 From $90, Keeps Buy Rating | MT |
May. 02 | UBS Adjusts Price Target on Bio-Techne to $90 From $80, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.11% | 13.26B | |
+29.21% | 49.18B | |
+0.84% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.29% | 26.09B | |
-22.70% | 18.71B | |
+32.02% | 12.32B | |
-0.63% | 11.99B | |
+24.55% | 11.97B |
- Stock Market
- Equities
- TECH Stock
- News Bio-Techne Corporation
- RBC Trims Price Target on Bio-Techne to $88 From $89 After Fiscal Q2 Miss, Maintains Sector Perform Rating